drugset / Trial / NCT04781075

Modified TAP (Transverse Abdominis Plane) Block in Colorectal Surgery

NCT04781075 ↗

Phase 4 Completed 76 enrolled Ochsner Health System
RandomizedParallel-groupSingle-blindTreatment

Summary

Single Blind, Randomized Controlled study to see if TAP Block with Exparel provides better pain relief than TAP Block with bupivicaine. Differences in Pain Scale, Length of Stay, and Total Narcotic use in the hospital will be evaluated.

Timeline

Start
2017-12-01
Primary completion
2020-12-31
Completion
2021-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 150 mg —
Comparator Bupivacaine Other / unclassified 266 mg —

Indications